[ad_1]
![[CytoReason in Mobi Health News] Israeli startup CytoReason joins forces with Ferring Pharmaceuticals to find new IBD treatment](https://blog.ourcrowd.com/wp-content/uploads/2018/02/mobihealthnews.jpg)
Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease (IBD).
Read more here.
[ad_2]
Source link
[CytoReason in Mobi Health News] Israeli startup CytoReason joins forces with Ferring Pharmaceuticals to find new IBD treatment
Related Posts
Leave a Reply
LATEST STORIES
Own and operated by The Ike Lemuwa Group, LLC a Commonwealth of Virginia Limited Liability Company, USA.
Info@nigeriasmartnews.com / info@ikelemuwagroup.com
Toll-Free: 1 888 642 8433
3821 Dominion Drive Dumfries, Virginia, 22026. USA